This contract opportunity involves the supply of oncology medications as specified in the requirements document and the list of batches. Suppliers are invited to provide the necessary pharmaceutical products to meet the needs of the healthcare sector. The contract is published by the "Prof. Dr. Th.
Tender closed on 16 Mar 2026. Awaiting award.
This contract involves the supply of various medicines as specified in the terms of reference and the attached list of lots. Suppliers are invited to provide a range of pharmaceutical products to meet the needs of the healthcare sector. The deadline for submissions is December 18, 2025. For more det
This contract opportunity involves the supply of oncology medications as specified in the requirements document. There are two lots: Lot 1 includes NAB-PACLITAXEL (Paclitaxel bound to albumin in nanoparticle form), and Lot 2 includes SACITUZUMAB GOVITECAN. Suppliers are invited to provide these medi
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.
UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.
Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.
